02.04.14: Not intended for U.S. and UK Media

Bayer Initiates Phase III Trial of Radium-223 Dichloride in Combination with Abiraterone Acetate for Patients with Metastatic Castration-Resistant Prostate Cancer mehr ...
Source: Bayer IR Newsfeed: Events - Category: Pharmaceuticals Source Type: news